HAG
WST icon

HighPoint Advisor Group’s West Pharmaceutical WST Stock Holding History

HighPoint Advisor Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,245
Closed -$343K – 1046
2025
Q4 		$343K Buy
1,245
+13
+1% +$3.56K 0.01% 798
2025
Q3 		$323K Sell
1,232
-12
-1% -$2.92K 0.02% 508
2025
Q2 		$272K Buy
1,244
+33
+3% +$7.05K 0.01% 553
2025
Q1 		$259K Sell
1,211
-308
-20% -$84.9K 0.02% 532
2024
Q4 		$490K Buy
1,519
+55
+4% +$17.3K 0.03% 385
2024
Q3 		$463K Sell
1,464
-23
-2% -$7.04K 0.03% 372
2024
Q2 		$445K Sell
1,487
-938
-39% -$331K 0.03% 381
2024
Q1 		$869K Buy
2,425
+50
+2% +$18.5K 0.06% 239
2023
Q4 		$922K Buy
+2,375
New +$841K 0.07% 230
2022
Q2 		$726K Buy
+2,300
New +$748K 0.08% 201
2021
Q3 		$407K Buy
+959
New +$404K 0.04% 345
2020
Q4 		– Sell
-1,229
Closed -$363K – 508
2020
Q3 		$363K Sell
1,229
-44
-3% -$11.6K 0.07% 236
2020
Q2 		$286K Buy
+1,273
New +$250K 0.06% 253
2019
Q4 		– Sell
-876
Closed -$129K – 478
2019
Q3 		$129K Sell
876
-162
-16% -$22.3K 0.03% 411
2019
Q2 		$127K Buy
+1,038
New +$123K 0.03% 398

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HighPoint Advisor Group's WST Position: Q1 2026 in Review

HighPoint Advisor Group sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 1,245 shares — an estimated $343K sold.

HighPoint Advisor Group first reported a position in WST in Q2 2019 and held it in 15 quarters. The position peaked at $922K in Q4 2023. 755 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • HighPoint Advisor Group reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • HighPoint Advisor Group sold 1,245 West Pharmaceutical shares in Q1 2026, an estimated $343K.
  • HighPoint Advisor Group first reported a position in West Pharmaceutical in Q2 2019 and held it in 15 quarters.
  • HighPoint Advisor Group's West Pharmaceutical position peaked at $922K in Q4 2023.
  • 755 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on HighPoint Advisor Group's 13F filing for Q1 2026, filed 14 May 2026.